Related Experiment Videos
Development of models for penicillamine-like drugs
Rheumatology and Rehabilitation
|August 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.
Breast cancer research and treatment·2003
Carnitine protects mitochondria and removes toxic acyls from xenobiotics.
Drugs under experimental and clinical research·2001
Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
Basic research in cardiology·2000
Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion.
International journal of tissue reactions·1999
Discovery of OT4003, a novel, potent, and orally active cys-LT1 receptor antagonist.
Bioorganic & medicinal chemistry·1997
Diclofenac sodium, diflunisal and naproxen: patient preferences for anti-inflammatory drugs in rheumatoid arthritis.
Rheumatology and rehabilitation·1982
Polymyalgia rheumatica in a defined elderly community.
Rheumatology and rehabilitation·1982
The recovery of the severely disable stroke patient.
Rheumatology and rehabilitation·1982
Multisystem presentation of eosinophilic fasciitis.
Rheumatology and rehabilitation·1982
Group G streptococcal arthritis.
Rheumatology and rehabilitation·1982
Clinical features of first attack of rheumatic fever in adults.
Rheumatology and rehabilitation·1982
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal of pharmaceutical analysis·2026
Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.
Biochemical and biophysical research communications·2026
Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.
EFSA journal. European Food Safety Authority·2026
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
New paradigm of q-CAR drug development targeting disease-specific protein conformations.
npj drug discovery·2026